API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2020/06/15/2048114/0/en/Adamis-Pharmaceuticals-Announces-License-to-Commercialize-Tempol-a-Novel-Investigational-Anti-inflammatory-and-Antioxidant-Drug-for-the-Treatment-of-Respiratory-Diseases-Including-.html